Jump to Header Jump to Main Content Jump to Footer

trials found matching your search:


Displaying 6 of 294 Results
Age
Type
Conditions or Disease:

Ph I Study of CB-03-10 with in Subjects with Advanced Solid Tumors

Farshid Dayyani

  • IRB INITIAL APPROVAL

PhIII Pirtobrutinib + Venetoclax & Rituximab vs Venetoclax & Rituximab in PrevTreated CLL/SLL

Susan O'Brien

  • OPEN TO ACCRUAL

Ph I/II Selective RET Inhibitor TAS0953/HM06 in Pts w/ Adv Solid Tumors with RET Gene Abnormalities

Sai-Hong Ignatius Ou

  • OPEN TO ACCRUAL

Study of inclisiran to prevent cardiovascular (CV) events in participants w/established CV disease.

Ailin Barseghian Elfarra

  • OPEN TO ACCRUAL

PhII Combo Atelizumab&CDX-1127 w/ or w/o Add of Cobimetinib in Prev Treated Unresec Biliary Tract Ca

Farshid Dayyani

  • OPEN TO ACCRUAL

Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III

Zeljka Jutric

  • OPEN TO ACCRUAL